eHealth, Inc.

NasdaqGS:EHTH Aktierapport

Börsvärde: US$61.2m

eHealth Tidigare resultatutveckling

Tidigare kriterier kontrolleras 0/6

eHealth har ökat intäkterna med en genomsnittlig årlig takt på 5.1%, medan Insurance -branschen såg intäkterna växande på 13% årligen. Intäkterna har varit fallande med en genomsnittlig takt på 1.8% per år.

Viktig information

5.07%

Tillväxttakt i vinsten

5.70%

Tillväxttakt för EPS

Insurance Tillväxt i branschen8.02%
Intäkternas tillväxttakt-1.81%
Avkastning på eget kapital4.11%
Nettomarginal-1.88%
Nästa resultatuppdatering06 May 2026

Senaste uppdateringar av tidigare prestationer

Recent updates

EHTH: Margin Discipline And New Offerings Will Reframe Long Term Prospects

Analysts have cut their price targets on eHealth significantly, with the consensus fair value moving from about $12.00 to roughly $3.00 as softer 2026 revenue guidance, reduced marketing spend from a major Medicare Advantage payor, and a tougher customer acquisition backdrop weigh on expectations. Analyst Commentary Recent Street research points to a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations after the 2026 revenue guide.

EHTH: Conservative 2026 Guide And Marketing Pullback Will Support Margin Repair

Analysts have cut the average price target on eHealth to about $2 to $3 per share, down sharply from prior targets near $8 to $9. They cite softer 2026 revenue guidance tied to reduced marketing spend by a key Medicare Advantage payor, conservative assumptions for the next annual enrollment period, and a planned pullback in some customer acquisition channels.

EHTH: Conservative 2026 Revenue Guide Will Support Margin Focused Turnaround

Analysts have cut the average price target for eHealth by $1.50, citing softer than expected 2026 revenue guidance, reduced marketing spend by a major Medicare Advantage payor, and company plans to scale back certain customer acquisition channels while carriers remain focused on margins. Analyst Commentary Recent Street research reflects a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations following the 2026 revenue guidance.

EHTH: Higher 2025 Earnings Guidance Will Support Margin Focused Turnaround

Analysts have sharply cut their average price target on eHealth from about $8.50 to roughly $3.75, reflecting lower $2 targets and a focus on weaker revenue expectations, along with an increased emphasis on margins and reduced customer acquisition spending. Analyst Commentary Recent research notes on eHealth highlight a meaningful reset in expectations, with price targets clustered around $2 and ratings largely at Hold.

EHTH: Higher 2025 Earnings Guidance Will Support Future Performance

Analysts have modestly adjusted their price target on eHealth to reflect a slightly higher discount rate and a small change in the assumed future P/E multiple, while keeping fair value steady at $8.50 as they reassess risk and valuation inputs without new Street research catalysts. What's in the News eHealth updated its earnings guidance for the year ending December 31, 2025, with total revenue now expected in a range of $540.0 million to $560.0 million, compared with the prior range of $525.0 million to $565.0 million (Key Developments).

Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 48% Lower

Feb 10
Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 48% Lower

EHTH: Enrollment Strength And Softer Competition Will Support Future Performance

Analysts have trimmed their price target on eHealth to US$9 from US$10, citing price adjustments even as the annual enrollment period tracks in line with expectations, supported by solid consumer demand and early signs of a more favorable competitive backdrop. Analyst Commentary Bullish Takeaways Bullish analysts point to the annual enrollment period tracking in line with internal expectations, which they see as a sign that execution is holding up against current industry conditions.

EHTH: Solid Enrollment Trends And Easing Competition Will Support Future Margins

Analysts have trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, along with signs of steady consumer demand and a somewhat more favorable competitive backdrop. Analyst Commentary Recent commentary around the price target cut frames eHealth as a company where execution looks generally on track, but with a valuation reset to reflect a more balanced risk and reward profile.

EHTH: Solid Enrollment Trends And Healthier Competition Will Support Margin Expansion

Analysts trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, solid consumer demand on the platform, and early indications of a more favorable competitive environment. Analyst Commentary Analysts see a mixed picture for eHealth at the current US$9 price target, with solid execution on core drivers balanced against questions on how much upside is justified in the near term.

EHTH: Strengthening Enrollment Trends Will Support Future Margin Expansion Potential

Analysts have trimmed their price target on eHealth from $10.00 to $9.00 per share, citing in-line annual enrollment trends supported by strong platform demand and early signs of a more favorable competitive environment. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the annual enrollment period is progressing in line with internal expectations, reinforcing confidence in management’s guidance and execution.

Further Upside For eHealth, Inc. (NASDAQ:EHTH) Shares Could Introduce Price Risks After 35% Bounce

Dec 19
Further Upside For eHealth, Inc. (NASDAQ:EHTH) Shares Could Introduce Price Risks After 35% Bounce

EHTH: Improving Enrollment Dynamics Will Support Future Upside Potential

Analysts have trimmed their price target on eHealth to $9 from $10, citing an annual enrollment period that is tracking in line with expectations, supported by solid consumer demand and a gradually improving competitive landscape. Analyst Commentary Analysts view the latest price target revision as a reflection of balanced expectations for eHealth, incorporating both the progress made in the current enrollment cycle and the lingering execution and competitive risks that could affect future growth and valuation.

EHTH: Future Enrollment Trends Will Support Further Upside Potential

Narrative Update on eHealth: Analyst Price Target Revised Analysts have slightly reduced their price target for eHealth, lowering it from $8.75 to $8.50. This revision is due to a modest decrease in revenue growth outlook and a marginally higher discount rate.

EHTH: Future Profit Margins Will Drive Upside Despite Consumer Confusion

Analysts have revised their price target for eHealth down from $9.25 to $8.75. They cite a significant reduction in projected profit margin, even though revenue growth forecasts have slightly improved and the estimated future price-to-earnings ratio is notably higher.

eHealth: Undervalued And Gaining Momentum After Q3 Earnings Beat

Nov 08

eHealth, Inc. (NASDAQ:EHTH) Held Back By Insufficient Growth Even After Shares Climb 34%

Oct 28
eHealth, Inc. (NASDAQ:EHTH) Held Back By Insufficient Growth Even After Shares Climb 34%

eHealth, Inc. (NASDAQ:EHTH) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Sep 03
eHealth, Inc. (NASDAQ:EHTH) Surges 26% Yet Its Low P/S Is No Reason For Excitement

The eHealth, Inc. (NASDAQ:EHTH) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Aug 09
The eHealth, Inc. (NASDAQ:EHTH) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

eHealth, Inc.'s (NASDAQ:EHTH) 26% Dip In Price Shows Sentiment Is Matching Revenues

May 15
eHealth, Inc.'s (NASDAQ:EHTH) 26% Dip In Price Shows Sentiment Is Matching Revenues
User avatar

Medicare Focus And AI Projects Will Improve Operations

Revenue and earnings growth driven by increased Medicare submissions, marketing investments, and enhanced enrollment margins.

Benign Growth For eHealth, Inc. (NASDAQ:EHTH) Underpins Stock's 30% Plummet

Mar 16
Benign Growth For eHealth, Inc. (NASDAQ:EHTH) Underpins Stock's 30% Plummet

eHealth: Another Big Run, Lock In, And Run House Money

Feb 26

Market Might Still Lack Some Conviction On eHealth, Inc. (NASDAQ:EHTH) Even After 66% Share Price Boost

Dec 23
Market Might Still Lack Some Conviction On eHealth, Inc. (NASDAQ:EHTH) Even After 66% Share Price Boost

Bull Run For EHealth, Inc.: Stock Flying On Solid Enrollment

Dec 17

A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price Climb

Nov 08
A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price Climb

Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump

Aug 30
Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump

We Think Some Shareholders May Hesitate To Increase eHealth, Inc.'s (NASDAQ:EHTH) CEO Compensation

Jun 06
We Think Some Shareholders May Hesitate To Increase eHealth, Inc.'s (NASDAQ:EHTH) CEO Compensation

Fördelning av intäkter och kostnader

Hur eHealth tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.


Resultat- och intäktshistorik

NasdaqGS:EHTH Intäkter, kostnader och resultat (USD Millions )
DatumIntäkterIntäkterG+A KostnaderFoU-kostnader
31 Dec 25554-1043452
30 Sep 25543143651
30 Jun 25547-844251
31 Mar 25553-1744953
31 Dec 24532-3544654
30 Sep 24465-7942855
30 Jun 24471-7243056
31 Mar 24472-6643158
31 Dec 23453-6742259
30 Sep 23402-9638564
30 Jun 23390-9537270
31 Mar 23374-10837073
31 Dec 22405-11940879
30 Sep 22453-17148277
30 Jun 22463-18451878
31 Mar 22509-16254380
31 Dec 21538-12353084
30 Sep 21588-2451582
30 Jun 216182249980
31 Mar 216114147973
31 Dec 205834545965
30 Sep 205917441762
30 Jun 205677840357
31 Mar 205447538154
31 Dec 195066734947
30 Sep 19339427540
30 Jun 19310623636
31 Mar 19277021633
31 Dec 18251019932
30 Sep 18200217432
30 Jun 18190916933
31 Mar 181922016733
31 Dec 171912516533
30 Sep 17151-1916432
30 Jun 17152-2315632
31 Mar 17155-2215432
31 Dec 16193015633
30 Sep 16193015734
30 Jun 16199915334
31 Mar 162021514334
31 Dec 15190-514936
30 Sep 15184-1214437
30 Jun 15187-1414340

Kvalitetsintäkter: EHTH är för närvarande olönsam.

Växande vinstmarginal: EHTH är för närvarande olönsam.


Fritt kassaflöde vs resultatanalys


Analys av tidigare vinsttillväxt

Resultatutveckling: EHTH är olönsam, men har minskat förlusterna under de senaste 5 åren med en hastighet av 5.1% per år.

Accelererande tillväxt: Det går inte att jämföra EHTH s intäktstillväxt under det senaste året med dess 5-åriga genomsnitt eftersom det för närvarande är olönsamt

Resultat vs industri: EHTH är olönsam, vilket gör det svårt att jämföra det senaste årets vinsttillväxt med Insurance branschen ( 35% ).


Avkastning på eget kapital

Hög ROE: EHTH har en negativ avkastning på eget kapital ( 4.11% ), eftersom det för närvarande är olönsamt.


Avkastning på tillgångar


Avkastning på sysselsatt kapital


Upptäck starka bolag som tidigare presterat bra

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/04/30 07:05
Aktiekurs vid dagens slut2026/04/30 00:00
Intäkter2025/12/31
Årlig intjäning2025/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

eHealth, Inc. bevakas av 25 analytiker. 5 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Steven ValiquetteBarclays
Steven ValiquetteBarclays
Nathaniel SchindlerBofA Global Research